Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
2 Growth Stocks That Are Beating Amazon Without Breaking a Sweat
10:53am, Saturday, 03'rd Sep 2022
They're both cornering specialized markets and growing aggressively in the process.
How Much Upside is Left in Jazz (JAZZ)? Wall Street Analysts Think 29%
11:34am, Thursday, 01'st Sep 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Jazz (JAZZ). While the effectiveness of this highly sought-after metric is questionable, the positive
Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
04:15pm, Wednesday, 31'st Aug 2022
DUBLIN , Aug. 31, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in the following upcoming investor conferences: Citi's 17th Annual BioP
Jazz Pharmaceuticals: Monopoly In The Narcolepsy Drug Market
08:35am, Wednesday, 24'th Aug 2022
Jazz has a monopoly on the market for narcolepsy drugs. Narcolepsy patients require daily medication to keep functioning properly throughout the day. The sales of oxybates can therefore be called stab
2 Top Healthcare Stocks Defying the Bear Market
10:07am, Monday, 22'nd Aug 2022
Not all companies are struggling right now.
Jazz (JAZZ) Starts Study on Epidiolex for a Fourth Indication
01:33pm, Friday, 19'th Aug 2022
Jazz Pharmaceuticals (JAZZ) initiates a two-part pivotal late-stage study evaluating its epilepsy drug, Epidiolex, in children and adolescents suffering from epilepsy with Myoclonic-Atonic Seizures (E
JAZZ or CORT: Which Is the Better Value Stock Right Now?
12:47pm, Tuesday, 09'th Aug 2022
JAZZ vs. CORT: Which Stock Is the Better Value Option?
Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales
03:04pm, Thursday, 04'th Aug 2022
JAZZ's Q2 earnings and sales beat expectations on strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. The company affirms its 2022 guidance.
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q2 2022 Results - Earnings Call Transcript
06:53pm, Wednesday, 03'rd Aug 2022
Jazz Pharmaceuticals plc (NASDAQ:JAZZ ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Andrea Flynn - Vice President & Head-Investor Relations Bruce Cozadd - Chairman
JAZZ vs. STVN: Which Stock Is the Better Value Option?
01:14pm, Thursday, 21'st Jul 2022
JAZZ vs. STVN: Which Stock Is the Better Value Option?
3 Reasons Why Jazz (JAZZ) Is a Great Growth Stock
01:55pm, Tuesday, 19'th Jul 2022
Jazz (JAZZ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Best Momentum Stocks to Buy for July 13th
11:32am, Wednesday, 13'th Jul 2022
JAZZ, GKOS and SPPI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 13, 2022.
3 Drugmaker Stocks Worth Buying to Boost Your Portfolio Health
10:45am, Wednesday, 13'th Jul 2022
Merck (MRK), Bayer (BAYRY) and Jazz Pharmaceuticals (JAZZ) are three large drugmakers that are good stocks to buy.
How Much Upside is Left in Jazz (JAZZ)? Wall Street Analysts Think 28%
11:35am, Tuesday, 12'th Jul 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 28.5% in Jazz (JAZZ). While the effectiveness of this highly sought-after metric is questionable, the positive
This Exciting Growth Sector Is Predicted to Keep Doubling Until 2028
07:23am, Thursday, 07'th Jul 2022
The cannabis pharmaceuticals market is still in its infancy.
